Related Experiment Video

Updated: Oct 5, 2025

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

18.1K

Beta-arrestins in the context of cardiovascular diseases: Focusing on angiotensin II type 1 receptor (AT1R)

Caroline Antunes Lino1, Maria Luiza Barreto-Chaves1

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.

Cellular Signalling
|January 25, 2022
PubMed

Insights

Beta-arrestin signaling regulates the harmful effects of the renin-angiotensin-aldosterone system, particularly through the angiotensin II type 1 receptor (AT1R). Understanding this pathway is key for cardiovascular drug discovery.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Signaling
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) are a major global health concern.
  • The renin-angiotensin-aldosterone system (RAAS) is critical for cardiovascular homeostasis.
  • Angiotensin II type 1 receptor (AT1R) activation by RAAS mediates detrimental cardiovascular effects.

Purpose of the Study:

  • To review recent advancements in beta-arrestin signaling within the cardiovascular system.
  • To highlight the role of beta-arrestin in angiotensin II type 1 receptor (AT1R) activation.
  • To discuss the implications for cardiovascular drug discovery.

Main Methods:

  • Literature review of beta-arrestin signaling pathways.
  • Focus on studies investigating AT1R activation and its downstream effects.
  • Analysis of beta-arrestin's role in receptor desensitization and internalization.

Main Results:

  • Beta-arrestins are multifunctional proteins involved in G protein-coupled receptor regulation.
  • Beta-arrestin signaling modulates AT1R activity in the cardiovascular system.
  • These pathways offer novel targets for therapeutic intervention in cardiovascular diseases.

Conclusions:

  • Beta-arrestin signaling is a crucial modulator of cardiovascular function.
  • Targeting beta-arrestin pathways associated with AT1R activation holds therapeutic potential for CVDs.
  • Further research into beta-arrestin signaling can advance cardiovascular medicine.

Keywords:
AT1RBiased-agonismCardiac hypertrophyHypertensionIschemia/reperfusion injuryMyocardial infarctionRenin-angiotensin-aldosterone systemSARS-CoV-2 infectionbeta-Arrestin signaling

More Related Videos

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

38.2K
Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy09:51

Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy

Published on: March 27, 2017

9.8K

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
1.0K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
686
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
877
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
551
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
988
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
969